olivlawolivlaw

olivLaw · European equity research

Materialise NV MTLS.BR

Belgium · Euronext Brussels · ISIN BE0974501331 · Vertical: Listed companies from Belgium

6.35EUR+0.79% · 1 dayClose 05 Nov 2026

Materialise NV, headquartered in Leuven (Belgium), develops software and provides industrial 3D printing services with applications in medicine, automotive and parts production. The company has been listed on both Nasdaq and Euronext Brussels since November 2025, which gives it a new liquidity base.

At the close of 05 Nov 2026, Materialise NV (MTLS.BR) stock was 6.35 EUR (+0.79% on the day), with market capitalisation 377.0 m EUR, P/E 48.8 on diluted EPS of 0.13 EUR over the last 12 months, beta 0.26, 52-week range 4.40–7.85 EUR.

Data as of · AI analysis dated · Source: ESEF annual reports and closing prices, computed by olivLaw.

Market cap
377.0 m EUR
shares as of 31 Dec 2025
P/E (TTM)
48.8
Diluted EPS TTM 0.13 · TTM to 31 Dec 2025
E/P (TTM)
2.05%
TTM to 31 Dec 2025
Dividend yield
unavailable
Beta (2y)
0.26
Volatility (1y) 50%
52-week range
4.407.85

Price history

Loading chart…

Technical reading

RSI (14)
40.3
weak (30–45)
Bollinger (20, 2)
5.99 – 8.19
in the lower half of the band · %B 0.16 · band width 31.1%
SMA 50 / 200
6.89 / 5.61
mixed trend
MACD (12, 26, 9)
-0.19 / -0.05
MACD below signal

Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).

Performance

CompanyEURO STOXX 50vs EURO STOXX 50Vertical median
1 month−17.0%+0.4%−17.4 pp—
3 months+7.6%−3.3%+10.9 pp—
6 months+38.0%+4.0%+34.1 pp—
Year to date+33.8%+8.1%+25.7 pp—
1 yearunavailable+10.7%unavailable+6.3%
3 yearsunavailable+50.1%unavailable−6.5%
5 yearsunavailable+43.6%unavailable—
Max drawdown (1y)
−21.7%
07 Oct 2026 → 28 Oct 2026
Max drawdown (5y)
−21.7%
07 Oct 2026 → 28 Oct 2026
Compound annual growth (5y)
unavailable
EURO STOXX 50 +7.5%

Price returns, dividends excluded.

Quarterly results

ESEF annual reports carry no quarters: the results are annual (below).

E/P over time

E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.

Today's P/E sits at the 100 percentile of its own 1-quarter history (min 36.5, median 36.5, max 36.5; quarters with earnings only).

Fiscal years

Fiscal year202320242025
Revenue256.1 m266.8 m267.6 m
Revenue YoYunavailable+4.2%+0.3%
Net income6.7 m13.4 m7.7 m
Net income YoYunavailable+99.9%−42.6%
Diluted EPS0.110.230.13
Diluted EPS YoYunavailable+109.1%−43.5%
net %2.6%5.0%2.9%
Free cash flow10.9 m6.8 m11.2 m

Balance sheet & financial health

Fiscal year 2025 · 31 Dec 2025

Cash
133.9 m EUR
Financial debt
49.7 m EUR
Net debt
-84.2 m EUR
Equity
255.5 m EUR
Total assets
420.6 m EUR
Debt / equity
0.19x
Current ratio
2.43x
ROE
3.1%
ROA
1.9%
FCF margin
4.2%

Financial statements (source on every figure)

Revenue and net income (EUR)

Margins

Income statement · EUR

Revenue
2023
256.1 m
2024
266.8 m
2025
267.6 m

esef· 29 Apr 2026verified

Cost of revenue
2023
111.0 m
2024
115.9 m
2025
114.7 m

esef· 29 Apr 2026verified

Gross profit
2023
145.1 m
2024
150.8 m
2025
152.9 m

esef· 29 Apr 2026verified

Research & development
2023
38.1 m
2024
44.4 m
2025
46.1 m

esef· 29 Apr 2026verified

Operating income
2023
5.6 m
2024
9.4 m
2025
8.9 m

esef· 29 Apr 2026verified

Interest expense
2023
3.9 m
2024
3.0 m
2025
5.6 m

esef· 29 Apr 2026verified

Pre-tax income
2023
6.8 m
2024
14.1 m
2025
7.3 m

esef· 29 Apr 2026verified

Income tax
2023
78.0 k
2024
733.0 k
2025
-429.0 k

esef· 29 Apr 2026verified

Net income
2023
6.7 m
2024
13.4 m
2025
7.7 m

esef· 29 Apr 2026verified

Diluted EPS
2023
0.11
2024
0.23
2025
0.13

esef· 29 Apr 2026verified

Balance sheet · EUR

Cash
2023
127.6 m
2024
102.3 m
2025
133.9 m

esef· 29 Apr 2026verified

Inventories
2023
17.0 m
2024
17.0 m
2025
14.9 m

esef· 29 Apr 2026verified

Current assets
2023
206.5 m
2024
190.5 m
2025
223.6 m

esef· 29 Apr 2026verified

Property, plant & equipment, net
2023
95.4 m
2024
111.3 m
2025
112.9 m

esef· 29 Apr 2026verified

Goodwill
2023
43.2 m
2024
43.4 m
2025
43.2 m

esef· 29 Apr 2026verified

Intangibles (excl. goodwill)
2023
31.5 m
2024
30.0 m
2025
25.6 m

esef· 29 Apr 2026verified

Total assets
2023
396.6 m
2024
396.3 m
2025
420.6 m

esef· 29 Apr 2026verified

Long-term debt
2023
33.6 m
2024
23.2 m
2025
49.7 m

esef· 29 Apr 2026verified

Current liabilities
2023
105.0 m
2024
102.2 m
2025
91.9 m

esef· 29 Apr 2026verified

Equity
2023
236.6 m
2024
248.5 m
2025
255.5 m

esef· 29 Apr 2026verified

Shares outstanding at year end
2023
61.1 m
2024
58.4 m
2025
59.4 m

esef· 29 Apr 2026derived

Cash flow · EUR

Operating cash flow
2023
20.2 m
2024
31.5 m
2025
25.3 m

esef· 29 Apr 2026verified

Capex
2023
9.2 m
2024
24.6 m
2025
14.1 m

esef· 29 Apr 2026verified

Free cash flow
2023
10.9 m ≈
2024
6.8 m ≈
2025
11.2 m ≈

esef· 29 Apr 2026derived

Investing cash flow
2023
-11.0 m
2024
-28.6 m
2025
-9.7 m

esef· 29 Apr 2026verified

Financing cash flow
2023
-22.4 m
2024
-27.6 m
2025
17.0 m

esef· 29 Apr 2026verified

Computed indicators

Growth

Revenue growth (YoY)
0.3%
computed by olivLawFY 2025
Revenue CAGR 3Y
unavailable
input data missing
Revenue CAGR 5Y
unavailable
input data missing
EBIT growth (YoY)
-5.3%
computed by olivLawFY 2025
Net income growth (YoY)
-42.6%
computed by olivLawFY 2025
Net income CAGR 3Y
unavailable
input data missing
Net income CAGR 5Y
unavailable
input data missing
EPS growth (YoY)
-43.5%
computed by olivLawFY 2025
EPS CAGR 3Y
unavailable
input data missing
EPS CAGR 5Y
unavailable
input data missing
FCF growth (YoY)
64.9%
computed by olivLawFY 2025

Profitability

Gross margin
57.1%
computed by olivLawFY 2025
EBITDA margin
unavailable
input data missing
EBIT margin
3.3%
computed by olivLawFY 2025
Net margin
2.9%
computed by olivLawFY 2025
FCF margin
4.2%
computed by olivLawFY 2025

Returns

ROE
3.1%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROA
1.9%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROIC
4.4%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
ROCE
2.7%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Payout ratio (EPS)
unavailable
input data missing
Payout ratio (FCF)
unavailable
input data missing

Balance sheet

Net debt
-84.2 m EUR
computed by olivLawbalance sheet at 31 Dec 2025
Net debt / EBITDA
unavailable
input data missing
Debt / equity
0.2x
computed by olivLawbalance sheet at 31 Dec 2025
Interest coverage
1.6x
computed by olivLawFY 2025

Liquidity

Current ratio
2.4x
computed by olivLawbalance sheet at 31 Dec 2025
Quick ratio
2.3x
computed by olivLawbalance sheet at 31 Dec 2025
Cash ratio
1.5x
computed by olivLawbalance sheet at 31 Dec 2025

Cash

Operating cash flow
25.3 m EUR
computed by olivLawFY 2025
Capital expenditure
14.1 m EUR
computed by olivLawFY 2025
Free cash flow
11.2 m EUR
computed by olivLawFY 2025
FCF conversion
145.5%
computed by olivLawFY 2025
Cash conversion
unavailable
input data missing

Efficiency

Days sales outstanding
unavailable
input data missing
Days inventory outstanding
51 days
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Days payables outstanding
unavailable
input data missing
Cash conversion cycle
unavailable
input data missing

Market and valuation

Market capitalisation
377.0 m EUR
computed by olivLawbalance sheet at 31 Dec 2025
Enterprise value
292.8 m EUR
computed by olivLawbalance sheet at 31 Dec 2025
Market cap / net income TTM
48.8x
computed by olivLawFY 2025
P/E (TTM)
48.8x
computed by olivLawFY 2025
Earnings yield
2.0%
computed by olivLawFY 2025
P/B
1.5x
computed by olivLawbalance sheet at 31 Dec 2025
P/S
1.4x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
EV/EBIT
32.8x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
EV/Sales
1.1x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
P/FCF
33.6x
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
FCF yield
3.0%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero
Shareholder yield (distributions)
unavailable
input data missing

1 indicators that do not apply to the sector.

Valuation

olivLaw classification

Insufficient data
What is missing
  • score weight coverage: 52.1% of at least 60%

A scoring methodology on indicators and valuation, not investment advice.

Closing price

6.35 EUR

05 Nov 2026Source: olivLaw, closing series

Market cap: 377.0 m EUR

Key indicators

Market capitalisation
377.0 m EUR
computed by olivLawbalance sheet at 31 Dec 2025
P/E (TTM)
48.8x
computed by olivLawFY 2025
P/B
1.5x
computed by olivLawbalance sheet at 31 Dec 2025
EV/EBITDA
unavailable
input data missing
ROE
3.1%
computed by olivLawFY 2025 · balance sheet at 31 Dec 2025
Net margin
2.9%
computed by olivLawFY 2025
Revenue growth (YoY)
0.3%
computed by olivLawFY 2025
Dividend yield
unavailable
no dividend in the structured statements; a missing line is not a confirmed zero

Coverage and freshness

26/37 reporting lines present
Latest full fiscal year: 2025
Latest reported period: 31 Dec 2025
Latest balance sheet date: 31 Dec 2025
Share count (cover of the latest filing), as of: 31 Dec 2025
Source: esefpublished 29 Apr 2026
verified 83derived 3

Score by group

52% · Insufficient data

Estimated value range

Low
3.19
EUR per share
Mid
3.90
EUR per share
High
5.12
EUR per share
Price: 6.35 EUR
The price is above the range
Potential to the central value: -38.5% (value / price − 1)
Margin of safety: -62.6% (1 − price / value)
Agreement between methods: low · 2 methods used · 2 independent bases

The combined range = the median of the valid methods' low, central and high values; it is not a probability interval and does not cover every result. Envelope of all methods: 1.38 – 7.17 EUR.

Valuation assumptions are editorial choices, not measured; beta is not measured.

Method ranges (EUR per share)

— — Mid · ▏ Price

Valuation methods

  • DCF (discounted cash flow)4.99 – 7.17 (Mid 5.81)
    WACC 8.0% · starting FCFF 15.9 m EUR · terminal value share of EV 75%
    The WACC × g sensitivity gives the method's bounds; these are not probabilities.
    Reverse DCF: starting growth implied by the price (fading linearly to terminal growth, everything else fixed): 5.4%
  • Peers: EV/EBITDAunavailable · input data missing
  • Peers: P/E1.38 – 3.07 (Mid 2.00)
    24 companies used · median multiple 15.4x · quartiles 10.6x – 23.6x
    ACKB.BR, AGS.BR, AZE.BR, BANI.BR, BAR.BR, BEKB.BR, BELYS.BR, BPOST.BR, CAMB.BR, CFEB.BR, COLR.BR, DECB.BR, DEME.BR, DIE.BR, ECONB.BR, ELI.BR, EVS.BR, FAGR.BR, FLOB.BR, FOU.BR, IBAB.BR, JEN.BR, KIN.BR, MELE.BR
  • Dividend discount (DDM)unavailable · the company pays no dividend: a dividend model needs an explicit initiation assumption

Assumptions (illustrative, editorial)

Risk-free rate
3.0%
Equity risk premium
5.5%
Beta (default)
1.00
Cost of equity
8.5%
Terminal growth
2.0%

Factor scorecard

Insufficient data

Minimum-evidence gate: score weight coverage: 52.1% of at least 60%

FactorValueScoreWeight used
ROIC · Quality4.4%26 (vs peers)20%
Net margin · Quality2.9%49 (vs peers)12%
FCF conversion · Quality145.5%100 (on a fixed band)12%
Revenue CAGR 3Y · Growthunavailableunavailable—
EPS CAGR 3Y · Growthunavailableunavailable—
Net debt / EBITDA · Balance sheetunavailableunavailable—
Interest coverage · Balance sheet1.6x1 (on a fixed band)12%
Current ratio · Balance sheet2.4x100 (on a fixed band)8%
P/E (TTM) · Valuation48.8x11 (vs peers)20%
EV/EBITDA · Valuationunavailableunavailable—
FCF yield · Valuation3.0%37 (on a fixed band)16%
Shareholder yield (distributions) · Returnsunavailableunavailable—
Payout ratio (FCF) · Returnsunavailableunavailable—

Factors without a value were dropped; the remaining weights were renormalised.

Score groups

  • Balance sheet41/100 · 2/3 factors with a value
  • Growth· partialunavailable · 0/2 factors with a value
  • Quality52/100 · 3/3 factors with a value
  • Returns· partialunavailable · 0/2 factors with a value
  • Valuation23/100 · 2/3 factors with a value

A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.

Memo

MATERIALISE (MTLS.BR). Latest full fiscal year: 2025; data up to 2025-12-31.

Figures computed from the financial statements: revenue 267.6 m EUR in 2025; YoY growth 0.3%; net margin 2.9%; ROE 3.1%.

The estimated value range is 3.19–5.12 EUR per share (median of 2 methods, agreement: low); assumptions are illustrative. Against the central value of 3.90 EUR, the price of 6.35 EUR leaves a potential of -38.5% (value / price − 1) and a margin of safety of -62.6% (1 − price / value). The range is the median of the methods' low, central and high values, not a probability interval.

Insufficient data for a verdict (score weight coverage: 52.1% of at least 60%).

Text generated deterministically from the figures shown; no language model. Not investment advice.

What supports the thesis

  • FCF conversion: 145.5%
  • Current ratio: 2.4x

What contradicts it

  • ROIC: 4.4%
  • Interest coverage: 1.6x
  • P/E (TTM): 48.8x
  • The price is above the estimated value range
  • The valuation methods diverge

Not assessed (insufficient data or a ratio without meaning): Revenue CAGR 3Y, EPS CAGR 3Y, Net debt / EBITDA, EV/EBITDA, Shareholder yield (distributions), Payout ratio (FCF).

Versus the vertical median

Listed companies from Belgium · same country · compared with 39 companies

Multiples and returns vs the median

P/E
48.8x
vertical median 17.2x
above median (+184.5%)
EV/EBITDA
—
vertical median 8.7x
P/S
1.4x
vertical median 1.0x
above median (+37.0%)
P/B
1.5x
vertical median 1.1x
above median (+32.3%)
ROE
3.1%
vertical median 8.3%
below median (−62.9%)
Net margin
2.9%
vertical median 3.8%
below median (−23.5%)
EBIT margin
3.3%
vertical median 7.9%
below median (−57.8%)
Revenue YoY
0.3%
vertical median 1.0%
below median (−67.1%)
Net debt/EBITDA
—
vertical median 0.5x
Dividend yield
—
vertical median 2.1%

Price rebased to 100 (monthly, 5 years)

Companies in the vertical

Market capP/EROENet marginRevenue YoY1A / 3A
ELI.BRElia Group11.9 bn23.39.6%13.6%−2.0%+28% / +34%
LOTB.BRLotus Bakeries11.4 bn66.420.9%12.7%+10.0%+82% / +76%
GBLB.BRGroupe Bruxelles Lambert - Groep Brussel Lambert10.6 bn82.40.8%2.1%+1.0%+6% / +9%
DIE.BRD'ieteren Group9.7 bn23.2—5.3%−1.5%+22% / +16%
ACKB.BRAckermans & Van Haaren8.8 bn22.28.4%7.6%+18.6%+22% / +77%
COLR.BRColruyt Group4.4 bn14.69.4%2.9%+3.1%+12% / −6%
DEME.BRDeme Group4.2 bn12.215.5%8.3%+1.3%+21% / +72%
AZE.BRAzelis Group2.9 bn16.16.6%4.3%+1.5%+29% / −42%
MELE.BRMelexis2.1 bn12.430.7%18.4%−3.3%−1% / −38%
BEKB.BRNV Bekaert SA2.1 bn30.73.1%1.8%−6.4%+10% / −5%
FAGR.BRFagron1.8 bn22.216.7%9.2%+14.3%+15% / +40%
KIN.BRKinepolis Group1.4 bn33.919.3%7.0%−4.5%+62% / +11%
JEN.BRJensen Group706.9 m17.215.1%9.1%+13.3%+28% / +111%
BAR.BRBarco563.5 m9.17.9%6.7%−9.9%−48% / −59%
IBAB.BRIon Beam Applications487.2 m39.510.7%2.1%+24.5%+48% / +52%
MTLS.BRMaterialise377.0 m48.83.1%2.9%+0.3%+21% / unavailable
DECB.BRDeceuninck341.3 m24.64.3%1.7%−4.5%+8% / +8%
CAMB.BRCampine272.3 m12.228.6%6.1%+13.4%−12% / +161%
CFEB.BRAannemingsmaatschappij Cfe266.8 m11.19.9%2.0%−5.3%+22% / +48%
EVS.BREvs Broadcast Equipment245.9 m6.020.8%21.7%+14.3%−49% / −36%
BPOST.BRBpost229.8 m3.56.3%1.5%−2.6%−39% / −75%
ECONB.BREconocom Group210.7 m40.51.2%0.2%+4.3%−1% / −36%
IMMO.BRImmobel172.2 m—-7.4%-25.2%−32.8%−24% / −36%
MONNI.BRKeyware Technologies171.0 m162.03.5%4.5%−5.9%−5% / −17%
HYSG.BRHybrid Software Group PLC121.3 m—-2.5%-5.5%+7.2%−4% / +13%

1- and 3-year price returns: for MTLS.BR from daily closes (the same as the performance table), for the other companies from month-end closes.

olivLaw engine forecast

The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.

The engine has no published run for this company yet.

Valuation scenarios (editable assumptions)

Illustrative scenarios

Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.

Bear
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Base
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Bull
Allowed range: -50 … 50%
Allowed range: -100 … 100%
Allowed range: 0 … 100
Allowed range: -10 … 20%
Allowed range: 0 … 100%
Nothing is saved.

Estimated price (EUR)

Estimated priceBearBaseBull
1 years
3.60
Total return -43% · Per year -43%
6.37
Total return 0% · Per year 0%
9.61
Total return 51% · Per year 51%
3 years
3.20
Total return -50% · Per year -20%
6.41
Total return 1% · Per year 0%
10.67
Total return 68% · Per year 19%
5 years
2.85
Total return -55% · Per year -15%
6.45
Total return 2% · Per year 0%
11.83
Total return 86% · Per year 13%
What moves the 3-year price the most
  • Exit P/E± 1.60
  • Net margin± 1.12
  • Annual revenue growth± 0.96
  • Annual dilution± 0.09

AI analysis

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

In brief

Materialise NV, headquartered in Leuven (Belgium), develops software and provides industrial 3D printing services with applications in medicine, automotive and parts production. The company has been listed on both Nasdaq and Euronext Brussels since November 2025, which gives it a new liquidity base 1.

SWOT

Strengths

  • Extensive international presence, with offices and service centres in several regions, supporting service to global clients 1.
  • Combination of specialised software and production services, which can build durable relationships with industrial clients 1.
  • Experience in medical applications, a niche with specialised demand and high barriers to entry 1.

Weaknesses

  • Concentration of control in the founders' hands limits the influence of external shareholders on strategy 1.
  • Reliance on leases for many sites can create cost uncertainty when contracts expire 1.
  • Share liquidity is split across two exchanges, which could fragment trading 1.

Opportunities

  • The Euronext Brussels listing could open access to European investors and additional financing options 1.
  • Expanding medical applications and custom parts production could raise revenue from higher-margin segments 1.
  • Share buyback programmes could become possible through the European listing, if the board decides 1.

Threats

  • Competition from equipment makers and software vendors could pressure margins 1.
  • Geopolitical instability in some regions where the company has staff and premises could affect operations 1.
  • Investment cycles of industrial clients can slow orders during periods of economic uncertainty 1.

Risks

  • Founders' majority controlhigh

    The founders control a majority of the votes, which may limit the influence of other shareholders over important decisions 1.

  • Geopolitical risksmedium

    Some facilities are located in regions affected by conflict, and the leases for these are treated as subject to short-term negotiation 1.

  • Expiry of rental contractsmedium

    Several leases expire in the near term, which could change operating costs if they are not renewed on similar terms 1.

  • Fragmented liquiditylow

    Trading on two exchanges could reduce volume on each market and could increase share price volatility 1.

  • Dependence on industrial cyclesmedium

    Revenue from industrial production can fluctuate with client investment, which could affect the predictability of results 1.

Investment thesis

What would need to be true (bull case)

  • If adoption of additive manufacturing grows in medicine and industry, the company could benefit from an expanding client base 1.
  • The Euronext Brussels listing could improve liquidity and provide flexibility in financing 1.
  • The combination of software and services can generate recurring revenue and close client relationships 1.

What would break the thesis

  • The founders' concentrated control could limit minority investors' influence over strategy 1.
  • Competitive pressure from equipment makers could compress margins over time 1.
  • If industrial investment slows, production orders could decline, affecting revenue predictability 1.

What to watch

  • First-quarter results, including revenue and margin trendsQ1 2026
  • First-half results and any updated guidanceQ2 2026
  • Renewal of leases expiring in 20262026
  • Liquidity development after the Euronext Brussels listingnext 10-K

Products, market & competition

AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.

The business

Materialise develops software for preparing and controlling 3D printing and offers additive manufacturing services to industrial and medical clients 1. Operations are organised around a main site in Leuven and a network of offices and service centres in Europe, the United States, Asia and South America, most of them leased 1. Ownership is concentrated: the founders control a majority of the votes, which shapes the company's governance 1.

The governance structure follows the Belgian one-tier board model, and the company applies Sarbanes-Oxley standards because of its Nasdaq listing 1. The board has ten members, four of whom are considered independent 1. Executive management is delegated to a management company represented by the chief executive officer 1.

The 2026 financial calendar includes first-quarter results in May, first-half results in August and third-quarter results in October 1. The company publishes quarterly reports, which allows activity to be tracked through the year 1.

Segments

Software and 3D printing services

The main segment combines file preparation software with production services for parts made by 3D printing 1. Revenue in this segment depends on the volume of industrial and medical orders 1.

Medical applications

Medical applications include surgical planning and personalised devices, an area in which the company operates through a network of laboratories and offices 1. If demand in this field grows, it could offset fluctuations in other industries 1.

Market context

The industrial 3D printing market is divided between equipment makers, software vendors and service bureaus, and Materialise is mainly active in software and services 1. The company's global presence, with offices in Europe, North America, Asia and South America, lets it serve clients in several regions 1.

Demand depends on the adoption of additive manufacturing in industries such as medicine and aerospace, where custom parts carry high value 1. If industrial investment in advanced manufacturing rises, expanding these applications could support the company's growth 1.

Trends

  • Dual listing on Euronext Brusselstailwind

    Since November 2025 the shares also trade on Euronext Brussels alongside Nasdaq, which could make it easier to access capital if needed 1.

  • Adoption of additive manufacturing in medicinetailwind

    Wider use of 3D printing for devices and surgical planning could expand the medical client base 1.

  • Concentrated shareholdingheadwind

    Majority control by the founders may limit minority shareholders' influence over strategic decisions, a factor relevant for investors 1.

  • Facility rental costsmixed

    Many facilities are leased under contracts with near expiry dates, and any renegotiation could change the cost structure 1.

Competitive position

Competition includes makers of 3D printing equipment, CAD software providers and additive manufacturing service bureaus, some with greater global scale 1. Materialise differentiates itself through the combination of specialised software and production services, as well as its experience in medical applications 1.

  • Industrial 3D printing equipment makers

    Companies that sell printing machines and compete for industrial clients' budgets; the exact list is not specified in the analysed source 1.

  • File preparation software vendors

    Providers of tools for preparing and optimising models for printing, competing directly with the company's solutions 1.

  • Additive manufacturing service bureaus

    Service providers that produce parts for clients and compete on price and quality of production 1.

  • CAD and engineering software providers

    Companies with design platforms that also include preparation modules for 3D printing 1.

News & filings

Sources

  1. [1] Annual report, fiscal year ended 2025-12-31 (ESEF) · SEC / Materialise NV · 31 Dec 2025

Figures computed by olivLaw from ESEF annual reports and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.